Clinical Trial Details

EORTC-18021

Back to Clinical Trials Database

Intravenous versus intra-arterial fotemustine chemotherapy in patients with liver metastases from uveal melanoma : a randomized phase III study of the EORTC Melanoma Group.

Study documentation

Trial Status All trial activities ended
Dates Date of activation: 28-Jan-2005
Date Step1 close: 08-Jun-2011
Data management at EORTC Yes
Design Phase 3
Randomized open label
Targeted Sample size EORTC Groups: 262
Treatment Fotemustine
Study Staff
Type of cancer
Participating groups EORTC Melanoma Group
Protocol summary http://clinicaltrials.gov/ct/show/NCT00110123
NCT number NCT00110123
EudraCT 2004-002245-12